Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 85,100 | 195,100 | 183,400 | 152,100 | 104,600 |
Receivables | 787,800 | 1,051,000 | 1,134,200 | 1,048,900 | 973,400 |
Inventories | 915,700 | 1,049,400 | 985,000 | 967,700 | 956,200 |
Other current assets | 853,300 | 262,900 | 271,800 | 276,700 | 247,400 |
TOTAL | $2,641,900 | $2,558,400 | $2,574,400 | $2,445,400 | $2,281,600 |
Non-Current Assets | |||||
PPE Net | 1,219,500 | 1,322,100 | 1,330,800 | 1,347,900 | 1,358,900 |
Investments And Advances | 137,800 | 0 | 0 | 0 | 74,900 |
Intangibles | 3,237,200 | 3,358,500 | 3,360,000 | 3,345,500 | 3,328,600 |
Other Non-Current Assets | 647,200 | 481,200 | 457,900 | 460,900 | 400,900 |
TOTAL | $5,241,700 | $5,161,800 | $5,148,700 | $5,154,300 | $5,163,300 |
Total Assets | $7,883,600 | $7,720,200 | $7,723,100 | $7,599,700 | $7,444,900 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 400 | 200,400 | 200,400 | 200,500 | 200,500 |
Accounts payable and accrued liabilities | 271,200 | 350,400 | 357,400 | 343,900 | 316,400 |
Accrued Expenses | 588,900 | 810,700 | 713,200 | 615,400 | 718,900 |
Other current liabilities | 7,200 | N/A | N/A | N/A | 24,700 |
TOTAL | $2,036,000 | $2,205,300 | $2,283,500 | $2,213,700 | $2,133,500 |
Non-Current Liabilities | |||||
Long Term Debt | 1,239,500 | 1,241,000 | 1,242,600 | 1,245,000 | 1,242,600 |
aiOther Non-Current Liabilities | 885,600 | 1,239,300 | 1,248,000 | 1,181,400 | 843,300 |
TOTAL | $2,716,900 | $2,633,300 | $2,650,400 | $2,592,900 | $2,591,900 |
Total Liabilities | $4,752,900 | $4,838,600 | $4,933,900 | $4,806,600 | $4,725,400 |
Shareholders' Equity | |||||
Shares Outstanding, K | 144,886 | 144,153 | 144,036 | 146,249 | 146,280 |
Common Shares | 717,400 | 717,400 | 717,400 | 717,400 | 717,400 |
Retained earnings | 5,447,200 | 5,293,100 | 5,161,500 | 5,037,800 | 4,925,800 |
Other shareholders' equity | 13,300 | -96,200 | -103,900 | -96,600 | -82,400 |
TOTAL | $3,130,700 | $2,881,600 | $2,789,200 | $2,793,100 | $2,719,500 |
Total Liabilities And Equity | $7,883,600 | $7,720,200 | $7,723,100 | $7,599,700 | $7,444,900 |